Sectors
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.
Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
